Found: 9
Select item for more details and to access through your institution.
Why Cancer?
- Published in:
- 2016
- By:
- Publication type:
- editorial
Cancer Drugs Fund 2.0: A Missed Opportunity?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cost Implications of Value-Based Pricing for Companion Diagnostic Tests in Precision Medicine.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Economic Evaluation of Mental Health Interventions: A Guide to Costing Approaches.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Discretely Integrated Condition Event (DICE) Simulation for Pharmacoeconomics.
- Published in:
- PharmacoEconomics, 2016, v. 34, n. 7, p. 665, doi. 10.1007/s40273-016-0394-z
- By:
- Publication type:
- Article
Trastuzumab Emtansine for Treating HER2-Positive, Unresectable, Locally Advanced or Metastatic Breast Cancer After Treatment with Trastuzumab and a Taxane: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer's Disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia.
- Published in:
- 2016
- By:
- Publication type:
- journal article